This story originally appeared on The Motley Fool. This month just might be the best time in a long time to buy cannabis stocks. Why? Much of the initial excitement about the increased prospects of significant U.S. cannabis reform has waned. With the Biden administration focused on other priorities, some investors …Read More »
This story originally appeared on The Motley Fool. Since the coronavirus market crash, stocks have been on a historic bull run. Over the past year, the S&P 500 and the Nasdaq Composite indices have surged in value a stunning 50% and 70%, respectively. But there are some signs the rally is running out of steam. Tesla and Palantir — two stocks retail investors …Read More »
This story originally appeared on Cannabis & Tech today. Cannabis and innovation go hand-in-hand. From growing to packaging technology, consuming to creating, cannabis influences many innovative ideas. Innovation in cannabis isn’t always as visible as it is in other industries. Cannabis is still budding and because it’s been illegal for so …Read More »
This story originally appeared on The Motley Fool. What happened Shares of Square (NYSE:SQ) popped 4.6% in noonday trading Wednesday. French investment bank Oddo BHF initiated coverage of Square this morning, TheFly.com reports, and Barclays (NYSE: BCS) just raised its price target on the point-of-sale credit card processor to $330. So what There’s not much detail on why Oddo …Read More »
This story originally appeared on CBD Testers. Delta 8 THC is a shelf-stable, mildly psychoactive, minor cannabinoid that has been quickly gaining popularity over the last couple years. Also climbing into the mainstream are products made with cannabis distillates, which allow for incredibly potent products with accurate dosing. When combined – …Read More »
This story originally appeared on Thestreet. See how cannabis stocks like Sundial Growers, Trulieve and Tilray performed last week after New York agreed to a deal to legalize marijuana use. The cannabis sector was down this past week as investors turned their backs on speculative stock plays and looked at …Read More »
This story originally appeared on The Motley Fool. The coronavirus pandemic swept up the world in 2020, upending life as we know it. One area feeling the pain was the college system. Last spring, students finished out the semester remotely across the nation. The change to remote learning also affected high …Read More »
This story originally appeared on The Motley Fool. The year 2020 was a good one for cannabis stocks, and 2021 is looking even better. Many investors find it hard to go all in on U.S. cannabis stocks, given that a lack of federal legalization keeps them from trading on the major …Read More »
This story originally appeared on Cannabis and Tech Today. Parkinson’s disease is a condition that affects populations all over the globe. In fact, it is estimated that over 10 million people live with the condition worldwide. Parkinson’s disease is a neurodegenerative health condition that affects the nerve cells in the brain that control …Read More »
This story originally appeared on The Fresh Toast. The last 10 years saw a dramatic increase in consumption and there is every reason to believe that the trend will continue. Cannabis business consulting firm Nucleus One recently released the findings of their February 2021 Massachusetts Adult-Use Marijuana Market Report. Nucleus-One tracks and analyzes …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!